SCHEMBL8088074

SCHEMBL8088074

O=CNc1nc2c(c3nc(-c4ccccc4)cn13)CCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 7/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 3/20 0.40
PKM P14618 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MITF O75030 1/20 0.40
HSD17B10 Q99714 4/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
ALOX15 P16050 1/20 0.38
RECQL P46063 1/20 0.38
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38
WDR5 P61964 2/20 0.37
GABRA1 P14867 1/20 0.37
GABRA2 P47869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9444178 0.84 GABRA3 (0.41) GABRA1GABRA2
SCHEMBL8096793 0.77 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8102864 0.77 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8103377 0.77 KDM4E (0.45) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8097140 0.74 ALDH1A1 (0.42) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8087741 0.69 GABRA3 (0.41) SMN1; SMN2TP53GABRA1GABRA2
SCHEMBL8094932 0.68 ALDH1A1 (0.46) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL8094714 0.68 GABRA2 (0.64) GABRA1GABRA2PIM1RPS6KB1CSNK1D
SCHEMBL8103272 0.65 GABRA3 (0.44) GABRA1GABRA2
SCHEMBL9259795 0.61 GABRA3 (0.41) GABRA1GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013799-A HIGHLY SELECTIVE AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR G-AMINOBUTYRIC ACID (GABA) BRAIN RECEPTORS; USEFUL IN DIAGNOSIS/TREATMENT OF ANXIETY, SLEEP, AND SEIZURE DISORDERS, DRUG OVERDOSE, AND ALERTNESS ENHANCEMENT ALERTNESS NEUROGEN CORPORATION (US) 2000-01-11 US disclosed
US-5696260-A AGONSIT, ANTAGONIST, PRODRUG; USEFUL IN DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP, SEIZURE DISORDER, OVERDOSE WITH BENZODIAZEPINE TYPE DRUGS AND ENHANCEMENT OF ALERTNESS NEUROGEN CORPORATION (US) 1997-12-09 US disclosed
US-5426186-A Diagnosis, treatment of anxiety, sleep and seizure disorders, benzodiazepine overdose; enhancement of alertness NEUROGEN CORPORATION (US) 1995-06-20 US disclosed
US-5185446-A Treating anxiety, sleep, seizure disorders NEUROGEN CORPORATION (US) 1993-02-09 US disclosed